Immunization Trials with Recombinant Major Sperm Protein of the Bovine Lungworm <i>Dictyocaulus viviparus</i>

The lungworm <i>Dictyocaulus viviparus</i> is one of the most economically important bovine parasites in temperate climate regions. Following infection, <i>D. viviparus</i> induces a temporary protective immunity, and a vaccine based on attenuated, infective larvae is commerc...

Full description

Bibliographic Details
Main Authors: Andrea Springer, Christian von Holtum, Georg von Samson-Himmelstjerna, Christina Strube
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Pathogens
Subjects:
Online Access:https://www.mdpi.com/2076-0817/11/1/55
_version_ 1797491321051545600
author Andrea Springer
Christian von Holtum
Georg von Samson-Himmelstjerna
Christina Strube
author_facet Andrea Springer
Christian von Holtum
Georg von Samson-Himmelstjerna
Christina Strube
author_sort Andrea Springer
collection DOAJ
description The lungworm <i>Dictyocaulus viviparus</i> is one of the most economically important bovine parasites in temperate climate regions. Following infection, <i>D. viviparus</i> induces a temporary protective immunity, and a vaccine based on attenuated, infective larvae is commercially available. However, due to several disadvantages of the live vaccine, the development of a recombinant subunit vaccine is highly desirable. Therefore, the major sperm protein (MSP), which is essential for the parasite’s reproduction, was tested as a recombinantly <i>Escherichia coli</i>-expressed glutathione-S-transferase (GST)-fused vaccine antigen in immunization trials with two different adjuvants, Quil A and Al(OH)<sub>3</sub>. Calves (N = 4 per group) were immunized on study day (SD) 0, 21 and 42 and given a challenge infection on SD 63–65. The two control groups received only the respective adjuvant. Based on geometric means (GM), a 53.64% reduction in larvae per female worm was observed in the rMSP Quil A group vs. its control group (arithmetic means (AM): 54.43%), but this difference was not statistically significant. In the rMSP Al(OH)<sub>3</sub> group, the mean number of larvae per female worm was even higher than in the respective control group (GM: 9.24%, AM: 14.14%). Furthermore, male and female worm burdens and the absolute number of larvae did not differ significantly, while the Al(OH)<sub>3</sub> control group harbored significantly longer worms than the vaccinated group. Vaccinated animals showed a rise in rMSP-specific antibodies, particularly IgG and its subclass IgG1, and the native protein was detected by immunoblots. Although rMSP alone did not lead to significantly reduced worm fecundity, it might still prove useful as part of a multi-component vaccine.
first_indexed 2024-03-10T00:45:49Z
format Article
id doaj.art-19d45b6d54614f179dedf95fba230950
institution Directory Open Access Journal
issn 2076-0817
language English
last_indexed 2024-03-10T00:45:49Z
publishDate 2022-01-01
publisher MDPI AG
record_format Article
series Pathogens
spelling doaj.art-19d45b6d54614f179dedf95fba2309502023-11-23T14:59:41ZengMDPI AGPathogens2076-08172022-01-011115510.3390/pathogens11010055Immunization Trials with Recombinant Major Sperm Protein of the Bovine Lungworm <i>Dictyocaulus viviparus</i>Andrea Springer0Christian von Holtum1Georg von Samson-Himmelstjerna2Christina Strube3Institute for Parasitology, Centre for Infection Medicine, University of Veterinary Medicine Hannover, 30559 Hannover, GermanyInstitute for Parasitology, Centre for Infection Medicine, University of Veterinary Medicine Hannover, 30559 Hannover, GermanyInstitute for Parasitology, Centre for Infection Medicine, University of Veterinary Medicine Hannover, 30559 Hannover, GermanyInstitute for Parasitology, Centre for Infection Medicine, University of Veterinary Medicine Hannover, 30559 Hannover, GermanyThe lungworm <i>Dictyocaulus viviparus</i> is one of the most economically important bovine parasites in temperate climate regions. Following infection, <i>D. viviparus</i> induces a temporary protective immunity, and a vaccine based on attenuated, infective larvae is commercially available. However, due to several disadvantages of the live vaccine, the development of a recombinant subunit vaccine is highly desirable. Therefore, the major sperm protein (MSP), which is essential for the parasite’s reproduction, was tested as a recombinantly <i>Escherichia coli</i>-expressed glutathione-S-transferase (GST)-fused vaccine antigen in immunization trials with two different adjuvants, Quil A and Al(OH)<sub>3</sub>. Calves (N = 4 per group) were immunized on study day (SD) 0, 21 and 42 and given a challenge infection on SD 63–65. The two control groups received only the respective adjuvant. Based on geometric means (GM), a 53.64% reduction in larvae per female worm was observed in the rMSP Quil A group vs. its control group (arithmetic means (AM): 54.43%), but this difference was not statistically significant. In the rMSP Al(OH)<sub>3</sub> group, the mean number of larvae per female worm was even higher than in the respective control group (GM: 9.24%, AM: 14.14%). Furthermore, male and female worm burdens and the absolute number of larvae did not differ significantly, while the Al(OH)<sub>3</sub> control group harbored significantly longer worms than the vaccinated group. Vaccinated animals showed a rise in rMSP-specific antibodies, particularly IgG and its subclass IgG1, and the native protein was detected by immunoblots. Although rMSP alone did not lead to significantly reduced worm fecundity, it might still prove useful as part of a multi-component vaccine.https://www.mdpi.com/2076-0817/11/1/55major sperm protein<i>Dictyocaulus viviparus</i>recombinant vaccinevaccinationimmunization
spellingShingle Andrea Springer
Christian von Holtum
Georg von Samson-Himmelstjerna
Christina Strube
Immunization Trials with Recombinant Major Sperm Protein of the Bovine Lungworm <i>Dictyocaulus viviparus</i>
Pathogens
major sperm protein
<i>Dictyocaulus viviparus</i>
recombinant vaccine
vaccination
immunization
title Immunization Trials with Recombinant Major Sperm Protein of the Bovine Lungworm <i>Dictyocaulus viviparus</i>
title_full Immunization Trials with Recombinant Major Sperm Protein of the Bovine Lungworm <i>Dictyocaulus viviparus</i>
title_fullStr Immunization Trials with Recombinant Major Sperm Protein of the Bovine Lungworm <i>Dictyocaulus viviparus</i>
title_full_unstemmed Immunization Trials with Recombinant Major Sperm Protein of the Bovine Lungworm <i>Dictyocaulus viviparus</i>
title_short Immunization Trials with Recombinant Major Sperm Protein of the Bovine Lungworm <i>Dictyocaulus viviparus</i>
title_sort immunization trials with recombinant major sperm protein of the bovine lungworm i dictyocaulus viviparus i
topic major sperm protein
<i>Dictyocaulus viviparus</i>
recombinant vaccine
vaccination
immunization
url https://www.mdpi.com/2076-0817/11/1/55
work_keys_str_mv AT andreaspringer immunizationtrialswithrecombinantmajorspermproteinofthebovinelungwormidictyocaulusviviparusi
AT christianvonholtum immunizationtrialswithrecombinantmajorspermproteinofthebovinelungwormidictyocaulusviviparusi
AT georgvonsamsonhimmelstjerna immunizationtrialswithrecombinantmajorspermproteinofthebovinelungwormidictyocaulusviviparusi
AT christinastrube immunizationtrialswithrecombinantmajorspermproteinofthebovinelungwormidictyocaulusviviparusi